4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-008846
CHIEF FINANCIAL OFFICER sold 15,944 shares at $23.11 ($368,466)
- CHIEF FINANCIAL OFFICER acquired 15,944 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-03-20 | Option exercise 10b5-1 | +15,944 | $12.97 | $206,794 | 39,326 | D |
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-03-20 | Sale 10b5-1 | −15,944 | $23.11 | $368,466 | 23,382 | D |
| Derivatives | |||||||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-03-20 | Option exercise · Share Option 10b5-1 | −15,944 | 8,374 | D | ||
| Open-market sales · 15,944 sh · avg $23.11 · $368,466 | |||||||
Loading xslF345X05/form4-03242025_080343.xml…